Functional haplotypes in the PTGDR gene fail to associate with asthma in two Australian populations

Respirology

Volumn 16, Issue 2, 2011, Pages 359-366

  Jamrozik, Euzebiusz F ^a   Warrington, Nicole ^a   McClenaghan, Jane ^a   Hui, Jennie ^a   Musk, Arthur W ^a,b   James, Alan ^a   Beilby, John P ^a,c   Hansen, Janice ^d   De Klerk, Nicholas H ^d   Palmer, Lyle J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c University of Western Australia ^*  (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

asthma; clinical epidemiology; genetics; haplotypes; prostaglandin D2 receptor

Indexed keywords

ADULT; ARTICLE; ASTHMA; AUSTRALIA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MUTATOR GENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PTGDR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ASTHMA; AUSTRALIA; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; IMMUNOGLOBULIN E; LONGITUDINAL STUDIES; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 79551539469     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01917.x     Document Type: Article

References (29)

1. Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur. Respir. J. 1995; 8: 483-91.
2. Braman SS,. The global burden of asthma. Chest 2006; 130 (1 Suppl.): 4S-12S.
3. Palmer LJ, Cookson WO,. Genomic approaches to understanding asthma. Genome Res. 2000; 10: 1280-7.
4. Kleeberger SR, Peden D,. Gene-environment interactions in asthma and other respiratory diseases. Annu. Rev. Med. 2005; 56: 383-400.
5. Zhang J, Pare PD, Sandford AJ,. Recent advances in asthma genetics. Respir. Res. 2008; 9: 4.
6. Chanock SJ, Manolio T, Boehnke M, et al. Replicating genotype-phenotype associations. Nature 2007; 447 (7145): 655-60.
7. Oguma T, Palmer LJ, Birben E, et al. Role of prostanoid DP receptor variants in susceptibility to asthma. N. Engl. J. Med. 2004; 351: 1752-63.
8. Sanz C, Isidoro-Garcia M, Davila I, et al. Promoter genetic variants of prostanoid DP receptor (PTGDR) gene in patients with asthma. Allergy 2006; 61: 543-8.
9. Li J, Liu Q, Wang P, et al. Lack of association between three promoter polymorphisms of PTGDR gene and asthma in a Chinese Han population. Int. J. Immunogenet. 2007; 34: 353-7.
10. Tsai YJ, Choudhry S, Kho J, et al. The PTGDR gene is not associated with asthma in 3 ethnically diverse populations. J. Allergy Clin. Immunol. 2006; 118: 1242-8.
11. Zhu G, Vestbo J, Lenney W, et al. Association of PTGDR gene polymorphisms with asthma in two Caucasian populations. Genes Immun. 2007; 8: 398-403.
12. Blakey JD, Sayers I, Ring SM, et al. Positionally cloned asthma susceptibility gene polymorphisms and disease risk in the British 1958 Birth Cohort. Thorax 2009; 64: 381-7.
13. Daley D, Lemire M, Akhabir L, et al. Analyses of associations with asthma in four asthma population samples from Canada and Australia. Hum. Genet. 2009; 125: 445-59.
14. Hardy CC, Robinson C, Tattersfield AE, et al. The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N. Engl. J. Med. 1984; 311: 209-13.
15. Wenzel SE, Westcott JY, Smith HR, et al. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am. Rev. Respir. Dis. 1989; 139: 450-7.
16. Matsuoka T, Hirata M, Tanaka H, et al. Prostaglandin D2 as a mediator of allergic asthma. Science 2000; 287 (5460): 2013-17.
17. James A, Palmer L, Kicic E, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am. J. Respir. Crit. Care Med. 2005; 171: 109-14.
18. Ryan G, Knuiman MW, Divitini ML, et al. Decline in lung function and mortality: the Busselton Health Study. J. Epidemiol. Community Health 1999; 53: 230-4.
19. Hansen J, Alessandri PT, Croft ML, et al. The Western Australian Register of Childhood Multiples: effects of questionnaire design and follow-up protocol on response rates and representativeness. Twin Res. 2004; 7: 149-61.
20. Allison DB,. Transmission-disequilibrium tests for quantitative traits. Am. J. Hum. Genet. 1997; 60: 676-90.
21. Rabinowitz D,. A transmission disequilibrium test for quantitative trait loci. Hum. Hered. 1997; 47: 342-50.
22. Abecasis GR, Cherny SS, Cookson WO, et al. Merlina-rapid analysis of dense genetic maps using sparse gene flow trees. Nat. Genet. 2002; 30: 97-101.
23. McCullagh P, Nelder J,. Generalized Linear Models. Chapman and Hall, London, 1989.
24. Laird NM,. Random-effects models for longitudinal data. Biometrics 1982; 38: 963-74.
25. Ober C, Hoffjan S,. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun. 2006; 7: 95-100.
26. Boie Y, Sawyer N, Slipetz DM, et al. Molecular cloning and characterization of the human prostanoid DP receptor. J. Biol. Chem. 1995; 270: 18910-16.
27. Sampson SE, Sampson AP, Costello JF,. Effect of inhaled prostaglandin D2 in normal and atopic subjects, and of pretreatment with leukotriene D4. Thorax 1997; 52: 513-18.
28. Daniels SE, Bhattacharrya S, James A, et al. A genome-wide search for quantitative trait loci underlying asthma. Nature 1996; 383 (6597): 247-50.
29. Mansur AH, Bishop DT, Markham AF, et al. Suggestive evidence for genetic linkage between IgE phenotypes and chromosome 14q markers. Am. J. Respir. Crit. Care Med. 1999; 159: 1796-802.